Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912 in Healthy Korean Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A First‐in‐Human, Double‐blind, Randomized, Placebo‐controlled, Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912 in Healthy Korean Subjects
Epistemonikos ID: c94482e2d4fc1adf6f7fecee967b193ba67c2590
First added on: May 22, 2024